ARAV Aravive Inc

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

As of 09/16/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/21/2014
Outstanding shares:  20,714,004
Average volume:  74,303
Market cap:   $80,991,756
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03890D108
ISIN:        US03890D1081
Sedol:      BGSGXX5
Valuation   (See tab for details)
PE ratio:   -4.21
PB ratio:   1.26
PS ratio:   8.32
Return on equity:   -46.54%
Net income %:   -306.42%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy